2022-03-112023-03-312023-03-31false13972139Isomab Ltd2023-09-1972110iso4217:GBPxbrli:pure139721392022-03-11139721392023-03-31139721392022-03-112023-03-31139721392022-03-10139721392022-03-10139721392022-03-102022-03-1013972139bus:Micro-entities2022-03-112023-03-3113972139bus:AuditExempt-NoAccountantsReport2022-03-112023-03-3113972139bus:FullAccounts2022-03-112023-03-3113972139bus:PrivateLimitedCompanyLtd2022-03-112023-03-3113972139core:WithinOneYear2023-03-3113972139core:AfterOneYear2023-03-3113972139core:WithinOneYear2022-03-1013972139core:AfterOneYear2022-03-1013972139dpl:CostSales2022-03-112023-03-3113972139dpl:AdministrativeExpenses2022-03-112023-03-3113972139dpl:DistributionCosts2022-03-112023-03-3113972139dpl:CostSales2022-03-102022-03-1013972139dpl:AdministrativeExpenses2022-03-102022-03-1013972139dpl:DistributionCosts2022-03-102022-03-1013972139core:WithinOneYear2023-03-3113972139core:AfterOneYear2023-03-3113972139core:WithinOneYear2022-03-1013972139core:AfterOneYear2022-03-1013972139core:WithinOneYear2022-03-112023-03-3113972139core:AfterOneYear2022-03-112023-03-3113972139bus:Director12022-03-112023-03-3113972139bus:Director22022-03-112023-03-3113972139bus:Director32022-03-112023-03-3113972139bus:Director42022-03-112023-03-31

Isomab Ltd

Registered Number
13972139
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2023

Isomab Ltd
Company Information
for the period from 11 March 2022 to 31 March 2023

Directors

BATES, David Owen, Professor
DESTECROIX, Harry, Dr
EDWARDS, Paul Martin
McKEN, Jackie Sarah

Registered Address

Biodiscovery Institute
University Park
Nottingham
NG7 2RD

Registered Number

13972139 (England and Wales)
Isomab Ltd
Statement of Financial Position
31 March 2023

2023
£

Fixed Assets1,679
Current Assets568,325
Prepayments and accrued income81,832
Creditors amounts falling due within one year(207,948)
Net current assets (liabilities)442,209
Total assets less current liabilities443,888
Accruals and deferred income(16,060)
Net assets (liabilities)427,828
Capital and reserves427,828
The financial statements were approved and authorised for issue by the Board of Directors on 19 September 2023, and are signed on its behalf by:
McKEN, Jackie Sarah
Director
Registered Company No. 13972139